Top Section/Ad
Top Section/Ad
Most recent
Calendar quirk could keep issuance going in December
◆ Praemia refis at a tighter coupon ◆ Schneider lands tight at the short end ◆ Minimal concessions needed
French biotech seeks to accelerate cancer vaccine program
◆ Single digit premiums offered ◆ Reverse Yankees dominating euro supply ◆ Floaters proving popular with multi-tranche issuers
More articles/Ad
More articles/Ad
More articles
-
Equity markets opened on a high on the first day of trading in 2021 and there are hopes that positive macro headwinds will provide strong momentum for equity capital markets deals. This is despite the Covid-19 pandemic still causing concern as cases rise and governments introduce tough restrictions to fight it. -
The US stimulus package seemed all but a done deal until Tuesday night. The $900bn, 5,593 page bill was passed by both houses and requires only President Donald Trump’s signature to become law. Though this seemed a foregone conclusion, Trump is threatening to withhold his signature unless the size of the relief is increased, not that bond markets seemed fazed by the late upset.
-
For years, meeting obligations has been the be-all and end-all of emerging market debt management. Pay your debts, or wave goodbye to international investors.
-
The closing of borders between mainland Europe and the UK has provided a brief glimpse into the chaos that the immediate imposition of trading restrictions between the UK and EU might caused in the event of a no-deal Brexit on December 31. Both sides need to work around the clock to finalise a deal with a generous implementation period to avoid the kind of nightmare scenario that could lead to investors fleeing the UK.
-
Gol, Brazil’s largest domestic airline, has priced a $200m six year private placement. This is one of the first deals from a Latin American airliner since the pandemic struck, and comes after a number of peers in the region have fallen into bankruptcy.
-
Equity investors have begun in recent months to allocate capital away from some of the high growth firms which dominated equity capital market supply this year to more cyclical companies that are set to benefit when economies reopen from Covid-19 lockdowns. They are also looking to buy into emerging markets, predicting rising equity valuations in places like Russia and some parts of Latin America.
